These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23288165)

  • 1. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.
    de Jager SC; Bot I; Kraaijeveld AO; Korporaal SJ; Bot M; van Santbrink PJ; van Berkel TJ; Kuiper J; Biessen EA
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):e75-83. PubMed ID: 23288165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.
    Zernecke A; Bot I; Djalali-Talab Y; Shagdarsuren E; Bidzhekov K; Meiler S; Krohn R; Schober A; Sperandio M; Soehnlein O; Bornemann J; Tacke F; Biessen EA; Weber C
    Circ Res; 2008 Feb; 102(2):209-17. PubMed ID: 17991882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
    Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.
    Herías V; Biessen EA; Beckers C; Delsing D; Liao M; Daemen MJ; Pham CC; Heeneman S
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):79-86. PubMed ID: 25395616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titration of the gap junction protein Connexin43 reduces atherogenesis.
    Morel S; Chanson M; Nguyen TD; Glass AM; Richani Sarieddine MZ; Meens MJ; Burnier L; Kwak BR; Taffet SM
    Thromb Haemost; 2014 Aug; 112(2):390-401. PubMed ID: 24828015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
    de Nooijer R; Bot I; von der Thüsen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.
    Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1474-8. PubMed ID: 15178562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
    Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
    Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
    Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.